Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer
- 30 November 2006
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (16) , 2738-2743
- https://doi.org/10.1016/j.ejca.2006.06.027
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancerAnnals of Oncology, 2005
- Capecitabine as Adjuvant Treatment for Stage III Colon CancerNew England Journal of Medicine, 2005
- Randomized crossover trial of intravenous 5-FU versus oral UFT both modulated by leucovorin: a one-centre experienceEuropean Journal of Cancer Care, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy GroupActa Oncologica, 2005
- Another Study of How to Give Fluorouracil?Journal of Clinical Oncology, 2003
- Dose-effect Relationship of Bolus 5-Fluorouracil in the Treatment of Advanced Colorectal CancerActa Oncologica, 2002
- Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorinEuropean Journal Of Cancer, 2002
- Bolus injection (2–4min) versus short-term (10–20min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trialEuropean Journal Of Cancer, 1998
- Sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic gastrointestinal cancerEuropean Journal of Cancer and Clinical Oncology, 1990